EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Bioventus's enterprise value is $710.7 Mil.
Bioventus's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was $522.7 Mil. Therefore, Bioventus's EV-to-Revenue for today is 1.36.
The historical rank and industry rank for Bioventus's EV-to-Revenue or its related term are showing as below:
BVS'
s EV-to-Revenue Range Over the Past 10 Years
Min: 0.99 Med: 1.69 Max: 2.93
Current: 1.36
During the past 9 years, the highest EV-to-Revenue of Bioventus was 2.93. The lowest was 0.99. And the median was 1.69.
BVS's EV-to-Revenue is ranked better than 76.15% of 826
companies
in the Medical Devices & Instruments industry
Industry Median: 3.265
vs BVS: 1.36
As of today (2024-05-12), Bioventus's stock price is $5.40.
Bioventus's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $8.30. Therefore, Bioventus's PS Ratio for today is 0.65.
Bioventus EV-to-Revenue Historical Data
The historical data trend for Bioventus's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Bioventus's EV-to-Revenue
For the Medical Devices subindustry, Bioventus's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bioventus's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bioventus's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Bioventus's EV-to-Revenue falls into.
Bioventus's current Enterprise Value is $710.7 Mil.
Bioventus's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $522.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bioventus's share price for today is $5.40.
Bioventus's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $8.30.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bioventus EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Bioventus's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in U.S and International markets.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BVS has been successfully added to your 